TSVT - 2seventy Bio Company Cash Volume

Corporate emblem and logo of 2seventybio.com (TSVT)

The premium pricing of Abecma therapy ensures high margins, which is reflected in the cash history of 2seventy bio, Inc. (TSVT). This parameter settled at 0.17, confirming liquidity. Financial stability is supported by strategic partnerships with pharma behemoths to implement CAR-T products, while operational efficiency is achieved by outsourcing manufacturing and clinical trials to third-party contractors.

2seventy bio, Inc - TSVT Company Cash Balance (period 07/04/2022 - 05/24/2025)

Financial and market metric breakdowns for 2seventy bio (TSVT)

- stock value and consensus price forecast:
- cash position and cash flow details:
Analysis of all company metrics:TSVT 2seventy bio, Inc.
Brand item of 2seventybio.com

Geopolitical barriers and supply chain disruptions in gene therapy create operational risks for 2seventy bio, Inc. (TSVT). Under these conditions, the calculated value of 0.17 demonstrates the company's actual liquidity on its accounts. This metric measures real cash reserves, determining the business's financial autonomy. Excess reserves ensure survival but reduce the overall return on equity. By analyzing the dynamics of cash balances, an investor assesses the company's resilience to external shocks.